Understanding the tissue-specific roles of MetAP2 and its alterations in metabolic diseases offers insights into potential therapeutic strategies targeting this enzyme to alleviate obesity, improve glucose homeostasis, and mitigate complications associated with T2DM. This evidence concerns the gene METAP2 and obesity disorder.